Showing 18,421 - 18,440 results of 46,478 for search '(( 5 ((wt decrease) OR (mean decrease)) ) OR ( 50 ((ng decrease) OR (a decrease)) ))', query time: 1.25s Refine Results
  1. 18421

    The therapeutic effects of human bone marrow-derived mesenchymal stem cells (MSCs) in IL-1RaKO mice. by Kijun Lee (4888660)

    Published 2018
    “…Scale bar: 200 μm (50×), 100 μm (100×), and 50 μm (200×). (D) Synovial hyperplasia and cellular infiltrate were each scored on a scale of 0–3. …”
  2. 18422

    CCBs preserve normal R<sub>in</sub> against EC-Aβ in the granule cells. by Hamid Gholami Pourbadie (692631)

    Published 2015
    “…<p>A, R<sub>in</sub> was significantly decreased in the granule cells from Aβ treated rats compared to the control group. …”
  3. 18423
  4. 18424
  5. 18425

    Optical coherence tomography findings. by Eisuke Usui (12111855)

    Published 2024
    “…On OCT, layered plaques were more frequently present in the culprit vessels in the %hDPV-decrease group than in the %hDPV-increase group (85.0% vs. 50.6%, P = 0.01). …”
  6. 18426

    S1 Data - by Eisuke Usui (12111855)

    Published 2024
    “…On OCT, layered plaques were more frequently present in the culprit vessels in the %hDPV-decrease group than in the %hDPV-increase group (85.0% vs. 50.6%, P = 0.01). …”
  7. 18427

    Clinical demographics and angiographic findings. by Eisuke Usui (12111855)

    Published 2024
    “…On OCT, layered plaques were more frequently present in the culprit vessels in the %hDPV-decrease group than in the %hDPV-increase group (85.0% vs. 50.6%, P = 0.01). …”
  8. 18428

    Physiological parameters. by Eisuke Usui (12111855)

    Published 2024
    “…On OCT, layered plaques were more frequently present in the culprit vessels in the %hDPV-decrease group than in the %hDPV-increase group (85.0% vs. 50.6%, P = 0.01). …”
  9. 18429
  10. 18430
  11. 18431
  12. 18432
  13. 18433

    Video1_Case Report: Three-dimensional printed prosthesis reconstruction for patello-femoral large osteochondral defects in a patient with distal femoral giant cell tumour: A case r... by Dechao Yuan (12995895)

    Published 2022
    “…At the last follow-up 27 months after surgery, she was pain free, the Musculoskeletal Tumour Society (MSTS) score improved from 15/30 to 29/30, the Visual Analogue Scale (VAS) score decreased from 7 to 0, and knee flexion increased from 50° to 130°. …”
  14. 18434
  15. 18435

    Key inputs in the model. by Jie Pan (187977)

    Published 2024
    “…Consequently, a scenario analysis based on subgroups of Chinese females was conducted for this study. …”
  16. 18436

    Table_1_A Meta-Analysis of the Effects of Foam Rolling on Performance and Recovery.pdf by Thimo Wiewelhove (804514)

    Published 2019
    “…The objective of this meta-analysis was to compare the effects of foam rolling applied before (pre-rolling as a warm-up activity) and after (post-rolling as a recovery strategy) exercise on sprint, jump, and strength performance as well as on flexibility and muscle pain outcomes and to identify whether self-massage with a foam roller or a roller massager is more effective. …”
  17. 18437

    Table_2_A Meta-Analysis of the Effects of Foam Rolling on Performance and Recovery.pdf by Thimo Wiewelhove (804514)

    Published 2019
    “…The objective of this meta-analysis was to compare the effects of foam rolling applied before (pre-rolling as a warm-up activity) and after (post-rolling as a recovery strategy) exercise on sprint, jump, and strength performance as well as on flexibility and muscle pain outcomes and to identify whether self-massage with a foam roller or a roller massager is more effective. …”
  18. 18438
  19. 18439

    Peptides of AnxA2 R1 domain interfere with the PCSK9≡LDLR interaction. by Nabil G. Seidah (148050)

    Published 2012
    “…The AlphaScreen luminescence signal was measured at 580 nm emission wavelength. The competition of AnxA2 peptides with the PCSK9≡LDLR interaction was revealed by a decrease in luminescence signal and demonstrated that the longest AnxA2 peptide (aa 25–97) inhibits binding of PCSK9 to LDLR with an IC<sub>50</sub> of 0.6 µM. …”
  20. 18440